论文部分内容阅读
[目的 ]观察雅达心达康治疗糖尿病自主神经病变 (DAN)对患者心率变异性 (HRV)和胰岛素抵抗 (IR)的影响。 [方法 ]DAN患者 5 9例随机分为 2组 ,心达康组 39例予以雅达心达康 10 m g,tid,Vit Bco组 2 0例以 Vit Bco治疗 ,共治疗 6个月 ,两组患者均于治疗前后作 HRV分析 ,测空腹血糖、糖化血红蛋白、胰岛素、红细胞山梨醇及血流变学。 [结果 ]治疗 6个月后与 Vit Bco组比较心达康组 HRV各项指标和胰岛素敏感指数均有不同程度改善 ,(P <0 .0 1)。 [结论 ]雅达心达康治疗 DAN能改善患者 HRV和 IR。
[Objective] To observe the effect of Yadaxin Daruma on heart rate variability (HRV) and insulin resistance (IR) in patients with diabetic autonomic neuropathy (DAN). [Methods] 59 cases of DAN patients were randomly divided into 2 groups, 39 cases of Xin Dakang Kang group of 10 patients, tid, Vit Bco group 20 cases treated with Vit Bco for a total of 6 months, two groups Before and after treatment in patients with HRV analysis of fasting blood glucose, glycosylated hemoglobin, insulin, erythrocyte sorbitol and hemorheology. [Result] The indexes of HRV and insulin sensitivity index in Xin Dakang group after 6 months of treatment were all improved to some extent (P <0. 01). [Conclusion] Astec XDK can improve HRV and IR in patients with DAN.